Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Abroad (travel likely)Recruiting

Conditions

Reccurent/Metastatic Solid Tumor Disease · Prostate Cancer (Post Prostatectomy) · Prostate Cancer · Prostatic Neoplasms · Neoplasm Recurrence, Local · Biochemical Recurrence of Malignant Neoplasm of Prostate

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Gatineau Hospital, Gatineau, Quebec, Canada
Contact: Study coordinator (Steven Tisseverasinghe, MD) · steven.tisseverasinghe.med@ssss.gouv.qc.ca · 819-966-6100
Hôpital Général Juif, Montreal, Quebec, Canada
Contact: Study coordinator (Tamim Niazi, MD) · tniazi@mcgill.ca · 514-340-8288
McGill University Health Centre, Montreal, Quebec, Canada
Contact: Study coordinator (James MG Tsui, MS, PhD) · james.tsui@mcgill.ca · 514-934-4400
CHU de Québec-Université Laval, Québec, Quebec, Canada
Contact: Study coordinator (Eric Vigneault, MD, MSc) · eric.vigneault.med@ssss.gouv.qc.ca · 418 691-5264
Contact: Study coordinator (Damien Carignan, PhD) · damien.carignan@crchudequebec.ulaval.ca · 418 525-4444

Study leads

Eric Vigneault, MD, MSc
Principal Investigator
CHU de Québec-Université Laval

View source on ClinicalTrials.gov